Routinely supporting investment banks, private equity sponsors, and multinational companies, Ropes & Gray LLP has vast experience of handling high-value IPOs and complex follow-on offerings. The practice is particularly active across the life sciences, biopharma, and financial services sectors, with the firm’s lawyers being especially well versed in the full range of equity corporate financing transactions. Leading from New York, both Craig Marcus and Paul Tropp specialize in representing both issuers and managers in transactions involving convertible, high-yield, and investment-grade bonds, alongside private placements. From Boston, Paul Kinsella predominantly focuses on securities offerings and governance matters, while in New York, Faiza Rahman is highly knowledgeable on acquisition finance and PIPEs, and Rachel Phillips mainly concentrates on equity and debt securities. Boston’s Thomas Fraser is also highlighted as key for his insight into strategic transactions and joint ventures.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Novavax Inc.
- Cullinan Therapeutics Inc.
- Foghorn Therapeutics Inc.
- LifeStance Health Inc.
- Hayward Holdings
- Surgery Partners Inc.
- iTeos Therapeutics Inc.
- TPG Capital LP
- American Industrial Partners
- Bain Capital LP N
Anwält*innen
Praxisleitung
Craig Marcus; Paul Tropp
Weitere Kernanwält*innen
Paul Kinsella; Faiza Rahman; Rachel Phillips; Thomas Fraser; Tara Fisher